Bayer 14372 Evaluate Efficacy and Safety of a Rivaroxaban Regimen Compared to Standard of Care


Clinical Trial

Offered by: Nemours Children's Specialty Care, Pensacola
Location: Pensacola, Fla.

Trial Name

Bayer 14372 Evaluate Efficacy and Safety of a Rivaroxaban Regimen Compared to Standard of Care

What is the trial about?

The purpose of this study is to determine the safety and efficacy of a blood thinner called rivaroxaban, which is taken as a pill or as an oral suspension, for children who were recently diagnosed with a blood clot.

Who can participate?

Your child (age 6 months to 18 years) may be eligible if he/she has a blood clot that was recently diagnosed.

What is involved?

If your child meets the study entry requirements and agrees to participate in this research study, the total time for this study is expected to be from 4 to 13 months. 

5 planned study visits. 4 planned blood draws.

Contact Nemours Clinical Trials

Trial Name: Bayer 14372 Evaluate Efficacy and Safety of a Rivaroxaban Regimen Compared to Standard of Care

Contact Information

(800) 354-5690
ClinicalTrials@nemours.org